Health Catalyst, Inc. (HCAT) Stock Score, Valuation & Financial Research
Health Catalyst, Inc. is in the Healthcare sector and Medical - Healthcare Information Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 23/100.
Quick answer for HCAT
Health Catalyst, Inc. currently has a Wall Street Score of 23/100. The stored market price is $1.73. Its financial score is 25/100. Its valuation score is 0/100. The latest WSS change is +0.1 points. These figures are a research snapshot, not a buy or sell recommendation.
What Health Catalyst, Inc. does
Health Catalyst, Inc. equips healthcare providers with crucial data and analytical technologies, alongside specialized services. Their extensive product line features a robust, enterprise-level data and analytics platform designed specifically for the healthcare sector. They additionally offer advanced artificial intelligence (AI) and data science solutions that integrate AI seamlessly into existing business intelligence tools, thereby enhancing analytical precision. The company's services also cover population health management, which identifies areas for improvement throughout the patient care journey, offering actionable recommendations and automated processes. For financial effectiveness, they provide critical insights into cost analysis, workforce efficiency, and revenue maximization. Moreover, Health Catalyst contributes to improving quality and safety by leveraging clinical and pa
HCAT financial snapshot
- Wall Street Score:
- 23/100
- Current price:
- $1.73
- Market capitalization:
- $127.8M
- Revenue:
- $292.2M
- Net income:
- $-264.8M
- Free cash flow:
- $-237K
- Cash:
- $60.6M
- Total debt:
- $170.0M
- EPS:
- -2.55
- Financial score:
- 25/100
- Valuation score:
- 0/100
- Revenue score:
- 22/100
What stands out
- Reported year-over-year revenue growth is -0.1%.
- Free cash flow is $-237K, showing cash burn in the current stored period.
- The balance sheet shows $60.6M of cash versus $170.0M of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.1 points: HCAT increased 0.1 points because Capital improved by 3 points.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 25/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-08-14.
How to research HCAT
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.